These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
42. Surgery for mucin-producing pancreatic tumor. Yasuda H; Takada T; Amano H; Yoshida M Hepatogastroenterology; 1998; 45(24):2009-15. PubMed ID: 9951855 [TBL] [Abstract][Full Text] [Related]
43. A large multicenter study of recurrence after surgical resection of branch-duct intraductal papillary mucinous neoplasm of the pancreas. Yan L; Siddiqui AA; Laique SN; Saumoy M; Kahaleh M; Yoo J; Kalra A; Mathew A; Sterling J; Rao R; Lieberman M; Cosgrove N; Sharaiha RZ Minerva Gastroenterol Dietol; 2017 Mar; 63(1):50-54. PubMed ID: 27824244 [TBL] [Abstract][Full Text] [Related]
44. Pancreatic juice cytology in the diagnosis of intraductal papillary mucinous neoplasm of the pancreas: significance of sampling by peroral pancreatoscopy. Yamaguchi T; Shirai Y; Ishihara T; Sudo K; Nakagawa A; Ito H; Miyazaki M; Nomura F; Saisho H Cancer; 2005 Dec; 104(12):2830-6. PubMed ID: 16287152 [TBL] [Abstract][Full Text] [Related]
45. Invasive IPMN and MCN: same organ, different outcomes? Kargozaran H; Vu V; Ray P; Bagaria S; Steen S; Ye X; Gagandeep S Ann Surg Oncol; 2011 Feb; 18(2):345-51. PubMed ID: 20809175 [TBL] [Abstract][Full Text] [Related]
46. Clinicopathological features and treatment of intraductal papillary mucinous tumour of the pancreas. Falconi M; Salvia R; Bassi C; Zamboni G; Talamini G; Pederzoli P Br J Surg; 2001 Mar; 88(3):376-81. PubMed ID: 11260102 [TBL] [Abstract][Full Text] [Related]
47. Predictors of malignant intraductal papillary mucinous neoplasm of the pancreas. Mimura T; Masuda A; Matsumoto I; Shiomi H; Yoshida S; Sugimoto M; Sanuki T; Yoshida M; Fujita T; Kutsumi H; Ku Y; Azuma T J Clin Gastroenterol; 2010 Oct; 44(9):e224-9. PubMed ID: 20453661 [TBL] [Abstract][Full Text] [Related]
48. Invasive carcinoma derived from the nonintestinal type intraductal papillary mucinous neoplasm of the pancreas has a poorer prognosis than that derived from the intestinal type. Sadakari Y; Ohuchida K; Nakata K; Ohtsuka T; Aishima S; Takahata S; Nakamura M; Mizumoto K; Tanaka M Surgery; 2010 Jun; 147(6):812-7. PubMed ID: 20060146 [TBL] [Abstract][Full Text] [Related]
49. Intraductal papillary mucinous neoplasms of the pancreas--predictors of malignancy. Fan F; Lai EC; Xie F; Yang JM; Xu F; Kan T; Shen RX; Yang XY; Lau Wan Y; Wu MC Hepatogastroenterology; 2010; 57(99-100):635-9. PubMed ID: 20698241 [TBL] [Abstract][Full Text] [Related]
50. Intraductal papillary or mucinous tumors (IPMT) of the pancreas: report of a case series and review of the literature. Zamora C; Sahel J; Cantu DG; Heyries L; Bernard JP; Bastid C; Payan MJ; Sielezneff I; Familiari L; Sastre B; Barthet M Am J Gastroenterol; 2001 May; 96(5):1441-7. PubMed ID: 11374680 [TBL] [Abstract][Full Text] [Related]
51. Intraductal papillary mucinous neoplasms of the pancreas: clinical and pathological features and diagnostic approach. Katabi N; Klimstra DS J Clin Pathol; 2008 Dec; 61(12):1303-13. PubMed ID: 18703569 [TBL] [Abstract][Full Text] [Related]
52. Characterization of CD24 expression in intraductal papillary mucinous neoplasms and ductal carcinoma of the pancreas. Ikenaga N; Ohuchida K; Mizumoto K; Yu J; Kayashima T; Hayashi A; Nakata K; Tanaka M Hum Pathol; 2010 Oct; 41(10):1466-74. PubMed ID: 20619441 [TBL] [Abstract][Full Text] [Related]
53. Intraductal papillary mucinous tumors of the pancreas: pancreatic resections guided by preoperative morphological assessment and intraoperative frozen section examination. Paye F; Sauvanet A; Terris B; Ponsot P; Vilgrain V; Hammel P; Bernades P; Ruszniewski P; Belghiti J Surgery; 2000 May; 127(5):536-44. PubMed ID: 10819062 [TBL] [Abstract][Full Text] [Related]
54. Development of ductal carcinoma of the pancreas during follow-up of branch duct intraductal papillary mucinous neoplasm of the pancreas. Uehara H; Nakaizumi A; Ishikawa O; Iishi H; Tatsumi K; Takakura R; Ishida T; Takano Y; Tanaka S; Takenaka A Gut; 2008 Nov; 57(11):1561-5. PubMed ID: 18477671 [TBL] [Abstract][Full Text] [Related]
56. p16 and p53 gene alterations and accumulations in the malignant evolution of intraductal papillary-mucinous tumors of the pancreas. Wada K J Hepatobiliary Pancreat Surg; 2002; 9(1):76-85. PubMed ID: 12021900 [TBL] [Abstract][Full Text] [Related]
57. Natural history of branch duct intraductal papillary-mucinous neoplasms of the pancreas without mural nodules: long-term follow-up results. Tanno S; Nakano Y; Nishikawa T; Nakamura K; Sasajima J; Minoguchi M; Mizukami Y; Yanagawa N; Fujii T; Obara T; Okumura T; Kohgo Y Gut; 2008 Mar; 57(3):339-43. PubMed ID: 17660227 [TBL] [Abstract][Full Text] [Related]
58. Clinical implication of morphological subtypes in management of intraductal papillary mucinous neoplasm. Yamada S; Fujii T; Shimoyama Y; Kanda M; Nakayama G; Sugimoto H; Koike M; Nomoto S; Fujiwara M; Nakao A; Kodera Y Ann Surg Oncol; 2014 Jul; 21(7):2444-52. PubMed ID: 24562937 [TBL] [Abstract][Full Text] [Related]
59. The prognosis of intraductal papillary mucinous tumors of the pancreas. Yamao K; Ohashi K; Nakamura T; Suzuki T; Shimizu Y; Nakamura Y; Horibe Y; Yanagisawa A; Nakao A; Nimuara Y; Naito Y; Hayakawa T Hepatogastroenterology; 2000; 47(34):1129-34. PubMed ID: 11020896 [TBL] [Abstract][Full Text] [Related]
60. Follow-up study after resection of intraductal papillary mucinous neoplasm of the pancreas; special references to the multifocal lesions and development of ductal carcinoma in the remnant pancreas. Ohtsuka T; Kono H; Tanabe R; Nagayoshi Y; Mori Y; Sadakari Y; Takahata S; Oda Y; Aishima S; Igarashi H; Ito T; Ishigami K; Nakamura M; Mizumoto K; Tanaka M Am J Surg; 2012 Jul; 204(1):44-8. PubMed ID: 21996346 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]